PDE4A and schizophrenia: This study used an fMRI-optimised version of the ID/ED attentional set-shifting task (Hampshire and Owen, 2006) to investigate the ability of the PDE4 inhibitor, roflumilast, to improve attentional set-shifting in patients with schizophrenia.